Latest Inhaler Stories
Meet the Next Generation of Monitored Medication Dispensers Pittsburgh, PA (PRWEB) April 04, 2012 In a world where technology keeps making everything
Adding inhaled powder mannitol to standard therapy for cystic fibrosis produced consistent lung function improvement for up to 52 weeks, according to this study. Mannitol treatment is not only efficient and safe, but it’s easy to administer as well.
Adding inhaled dry powder mannitol to standard therapy for cystic fibrosis produced sustained improvement in lung function for up to 52 weeks.
More Images (2 images) »